Literature DB >> 19330201

Clinical and molecular neuroimaging characteristics of Brazilian patients with Parkinson's disease and mutations in PARK2 or PARK8 genes.

Orlando G P Barsottini1, Andre C Felício, Patricia de Carvalho Aguiar, Clecio Godeiro-Junior, Ming C Shih, Marcelo Q Hoexter, Rodrigo A Bressan, Henrique B Ferraz, Luiz Augusto F Andrade.   

Abstract

OBJECTIVE: To describe clinical and neuroimaging (SPECT) characteristics of Brazilian patients with Parkinson's disease (PD) and mutations in PARK2 or PARK8 genes.
METHOD: A total of 119 patients meeting clinical criteria for PD were evaluated.
RESULTS: Of all patients studied, 13 had mutations in either PARK2 (n=9) or PARK8 genes (n=4). No statistically significant differences in clinical characteristics in both groups were seen. SPECT with [99mTc] TRODAT-1 showed significant differences between patient and control and the most remarkable difference was between PARK2 and control.
CONCLUSION: The study found a frequency of mutation of 10.1% and it was most commonly seen in women. These patients had long disease course and high rates of dyskinesia after L-DOPA use. PARK8 patients did not have a relevant family history of PD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330201     DOI: 10.1590/s0004-282x2009000100003

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  A Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics.

Authors:  Mario R Cornejo-Olivas; Luis Torres; Ignacio F Mata; Pilar Mazzetti; Diana Rivas; Carlos Cosentino; Miguel Inca-Martinez; Juan M Cuba; Cyrus P Zabetian; James B Leverenz
Journal:  Parkinsonism Relat Disord       Date:  2015-01-15       Impact factor: 4.891

2.  Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.

Authors:  Alisdair McNeill; Ruey-Meei Wu; Kai-Yuan Tzen; Patricia C Aguiar; Jose M Arbelo; Paolo Barone; Kailash Bhatia; Orlando Barsottini; Vincenzo Bonifati; Sevasti Bostantjopoulou; Rodrigo Bressan; Giovanni Cossu; Pietro Cortelli; Andre Felicio; Henrique B Ferraz; Joanna Herrera; Henry Houlden; Marcelo Hoexter; Concepcion Isla; Andrew Lees; Oswaldo Lorenzo-Betancor; Niccolo E Mencacci; Pau Pastor; Sabina Pappata; Maria Teresa Pellecchia; Laura Silveria-Moriyama; Andrea Varrone; Tom Foltynie; Anthony H V Schapira
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

Review 3.  Review of the epidemiology and variability of LRRK2 non-p.Gly2019Ser pathogenic mutations in Parkinson's disease.

Authors:  Paweł Turski; Iwona Chaberska; Piotr Szukało; Paulina Pyska; Łukasz Milanowski; Stanisław Szlufik; Monika Figura; Dorota Hoffman-Zacharska; Joanna Siuda; Dariusz Koziorowski
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.